Overview
What is Foundation For Innovative New Diagnostics?
Foundation For Innovative New Diagnostics (FIND) is a global nonprofit organization based in Geneva, Switzerland. With a mission to address diagnostic inequities and advance research and development (R&D) in low-resource areas, FIND plays a crucial role in enhancing access to essential diagnostic tools. In the context of the COVID-19 pandemic, FIND led major diagnostic manufacturing advancements, establishing capacity for 60 million COVID-19 rapid tests and self-tests per month in low- and middle-income countries (LMICs). This nonprofit organization has facilitated technology transfer programs, enabling local manufacturers like Diatropix (Senegal) and Premier Medical Corporation (India) to produce high-quality COVID-19 rapid diagnostic tests. FIND's efforts have resulted in WHO Emergency Use Listing (EUL) for several COVID-19 tests, helping bridge the diagnostic gap in resource-limited settings. Additionally, FIND supports decentralized community-based testing and test-and-treat strategies, ensuring effective implementation and monitoring of diagnostic solutions. With a workforce of 132 dedicated individuals, FIND acts as a catalyst in bridging the gap between technology development, policy, and clinical care, ultimately improving healthcare access in LMICs.
Official website here: www.finddx.org
Is Foundation For Innovative New Diagnostics legitimate?
Foundation For Innovative New Diagnostics is a legitimate nonprofit organization registered as a 501(c)(3) entity. Foundation For Innovative New Diagnostics submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $2,467,485
Professional Fundraising Fees: $0
Other Salaries and Wages: $15,627,720
For more financial information, click here
Official website here: www.finddx.org
What is the mission statement of Foundation For Innovative New Diagnostics?
Foundation For Innovative New Diagnostics (FIND) is an international non-profit organization dedicated to enabling the development and delivery of essential diagnostic tests for poverty-related diseases. FIND acts as a catalyst, bridging the gap between experts in technology development, policy, and clinical care. By reducing barriers to innovation and effective implementation, FIND facilitates the accessibility of diagnostic solutions in low- and middle-income countries.
Official website here: www.finddx.org
Who is the CEO of Foundation For Innovative New Diagnostics?
Norma Torres is the Chief Executive Officer of Foundation For Innovative New Diagnostics. The CEO's salary of Foundation For Innovative New Diagnostics is $323,816 and their total compensation is $421,585.
Official website here: www.finddx.org
What is the revenue of Foundation For Innovative New Diagnostics?
Foundation For Innovative New Diagnostics's revenue in 2022 was $144,248,069.
Official website here: www.finddx.org
Who are the executives of Foundation For Innovative New Diagnostics and what are their salaries?
The average compensation at Foundation For Innovative New Diagnostics during 2022 was $137,085. There are 132 employees and 6 volunteers at Foundation For Innovative New Diagnostics.
Here are 30 key members and their salaries (Foundation For Innovative New Diagnostics's CEO's salary is $323,816 and their total compensation is $421,585):
- William Rodriguez (Chief Executive Officer)
- Sergio Carmona (Chief Medical Officer)
- Louisa Chaubert (Director Of Finance)
- Emma Jane Hannay (Chief Access Officer)
- Willo Brock Start 922 (Vp,External Affairs)
- Daniel Bausch (Sr. Advisor, Global Health Sec)
- Marta Fernandez Suarez (Chief Technology Officer)
- Morten Ruhwald (Director, Tb Programme)
- Sharon Saacks (Director Of Operations)
- Beatrice Mouton (Director, Human Resources)
- Stefano Ongarello (Director, Data Science)
- Sylvain Bieler (Senior Scientist)
- Sanjay Sarin (Vp, Access)
- Aditi Srinivasan (Director, Data Science)
- Cassandra Kelly-Cirinostart922 (Vp; Health Programmes)
- Mark Kessel End 1122 (Chairman Of The Board) [Trustee/Director]
- Daniel Robert Camus (Member Of The Board) [Trustee/Director]
- Andrew John Jack End 1122 (Member Of The Board) [Trustee/Director]
- Iona Kickbush (Member Of The Board) [Trustee/Director]
- Carlos Morel Medicis (Member Of The Board) [Trustee/Director]
- Marcel Tanner (Member Of The Board) [Trustee/Director]
- Sheila Tlou End 922 (Member Of The Board) [Trustee/Director]
- Michael Watson End 922 (Member Of The Board) [Trustee/Director]
- David Heymann (Member Of The Board) [Trustee/Director]
- Gao Fu End 922 (Member Of The Board) [Trustee/Director]
- Kamineni Shobana (Member Of The Board) [Trustee/Director]
- Frutiger Christian (Board Member) [Trustee/Director]
- Ayoade Alakija Start 1122 (Chairman Of The Board) [Trustee/Director]
- Soumya Swaminathanstart1122 (Member Of The Board) [Trustee/Director]
- Precious Matsoso Start 1122 (Member Of The Board) [Trustee/Director]
Official website here: www.finddx.org
Where can I find the form 990 for Foundation For Innovative New Diagnostics?
The Foundation For Innovative New Diagnostics’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.finddx.org
Learn more at the official website: www.finddx.org
Mission Statement of Foundation For Innovative New Diagnostics
Foundation For Innovative New Diagnostics (FIND) is a international non-profit organization that facilitates the creation and distribution of affordable diagnostic tests for poverty-related diseases in low- and middle-income countries. Acting as a bridge between technology developers, policymakers, and clinical care providers, FIND reduces barriers to innovation and ensures the effective implementation of diagnostic solutions in resource-limited settings. By enabling the development and delivery of necessary diagnostic tests, FIND aims to improve health outcomes and save lives.
Impact
This information is meant to be a general summary of Foundation For Innovative New Diagnostics. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
Foundation For Innovative New Diagnostics has had a significant impact in advancing the development and implementation of new, low-cost diagnostics for infectious diseases in low-resource areas. Specifically, in response to the COVID-19 pandemic, FIND invested over USD 103 million in 2022 to address access inequities and support diagnostics research and development. This led to major advancements in regional diagnostics manufacturing, with over 60 million COVID-19 rapid tests being produced per month in low- and middle-income countries at a cost of US$1-2 per test.
FIND's efforts also facilitated technology transfer programs, enabling the production of high-quality COVID-19 rapid diagnostic tests in countries like Senegal, India, Brazil, China, and South Africa. Additionally, FIND's support helped companies achieve WHO Emergency Use Listing for their COVID-19 tests, ensuring their quality and efficacy.
Furthermore, FIND played a crucial role in generating independent trial data to support the WHO Emergency Use Listing of several COVID-19 tests, contributing to the assessment of test accuracy and effectiveness in detecting new variants of the virus. FIND also supported decentralized community-based testing, test-and-treat strategies, and the procurement of nearly 1.9 million diagnostic tests in 26 countries, notably supporting the introduction of COVID-19 Ag rapid diagnostic tests.
Overall, Foundation For Innovative New Diagnostics' impact extends beyond research and development to actively promoting access to essential diagnostics in underserved regions, thereby improving healthcare outcomes and contributing to the global fight against infectious diseases.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Organization Details
Founding Year
2003
Phone
0000000000
Principal Officer
Norma Torres
Website
www.finddx.org
NTEE Category
Code: G90 - Disease
If you are a representative of Foundation For Innovative New Diagnostics and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.